Yoshihiro Otani

发表

The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology

D. Capper, K. Ichimura, T. Yasuhara, 2022, Journal of Neuro-Oncology.

Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research

B. Kaur, R. Barth, Y. Otani, 2022, Journal of neuropathology and experimental neurology.

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

Mohammed A. Ismael, C. Möller-Levet, N. Annels, 2022, BMC cancer.

Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases

T. Yasuhara, I. Date, H. Yanai, 2021, NMC case report journal.

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

I. Date, Y. Tomita, S. Hirano, 2021, Acta neuropathologica communications.

Glioma and temozolomide induced alterations in gut microbiome

L. McCullough, Takeshi Takayasu, N. Tandon, 2020, Scientific Reports.

Clinicopathological and genetic features of supratentorial cortical ependymomas.

I. Date, T. Ichikawa, Y. Otani, 2019, World neurosurgery.

Dynamic Reorganization of Microtubule and Glioma Invasion.

I. Date, T. Ichikawa, Y. Otani, 2019, Acta medica Okayama.

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors

B. Kaur, Ningyan Zhang, Z. An, 2021, bioRxiv.

Comparative Histologic and Molecular Analysis of 2 Recurrent Lesions Showing Different Magnetic Resonance Imaging Responses After Bevacizumab Treatment: Report of a Case of Anaplastic Astrocytoma.

I. Date, T. Ichikawa, Y. Otani, 2018, World neurosurgery.

A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy

M. Sakaguchi, Masami Watanabe, I. Date, 2016, Scientific Reports.

Phenotypic Transition as a Survival Strategy of Glioma

I. Date, T. Ichikawa, Y. Otani, 2016, Neurologia medico-chirurgica.

Implications of immune cells in oncolytic herpes simplex virotherapy for glioma

I. Date, B. Kaur, J. Yoo, 2022, Brain Tumor Pathology.

PKR induces TGF-β and limits oncolytic immune therapy

M. Caligiuri, Guangsheng Pei, B. Kaur, 2023, Journal for ImmunoTherapy of Cancer.

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

N. Ueno, A. Yamaguchi, Ningyan Zhang, 2020, Nature Communications.

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis

S. Hirano, H. Michiue, K. Fujii, 2022, PloS one.

[A case of synovial sarcoma with brain metastasis treated with surgical resection and stereotactic radiosurgery].

T. Ozaki, I. Date, H. Yanai, 2013, No shinkei geka. Neurological surgery.

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44

Zhongming Zhao, G. Calin, Young-Jun Jeon, 2021, Scientific Reports.

Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas

K. Ichimura, K. Satomi, Y. Otani, 2023, Brain Tumor Pathology.

Rodent Brain Tumor Models for Neuro-Oncology Research

B. Kaur, Y. Otani, R. McCormack, 2021, Molecular Pathology Library.

Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies

K. Kiura, K. Nishio, K. Kunimasa, 2023, International journal of cancer.

Congenital Glioblastoma with Distinct Clinical and Molecular Characteristics: Case Reports and a Literature Review.

K. Ichimura, M. Kameda, I. Date, 2017, World neurosurgery.

Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma

I. Date, T. Ichikawa, Y. Otani, 2015, Brain Tumor Pathology.

Hybrid Microscopic-Endoscopic Surgery for Craniopharyngioma in Neurosurgical Suite: Technical Notes.

I. Date, T. Ichikawa, S. Ono, 2016, World neurosurgery.

IDH-mutant Astrocytoma Arising in the Brainstem with Symptom Improvement by Foramen Magnum Decompression: A Case Report

T. Yasuhara, Y. Otani, A. Uneda, 2023, NMC case report journal.

Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.

Y. Horio, E. Sasaki, K. Masago, 2024, Journal of neuro-oncology.

Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion

Y. Matsumoto, I. Date, Y. Tomita, 2018, Oncogene.

Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion Authors:

I. Date, Y. Tomita, S. Inoue, 2017 .

Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review

S. Koizumi, K. Fujii, K. Kurozumi, 2024, Journal of neuro-oncology.

Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.

D. Maric, B. Kaur, J. Yoo, 2020, Neuro-oncology.

Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

I. Date, B. Kaur, Y. Tomita, 2019, Molecular Cancer Therapeutics.

Oncolytic HSV–Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition

M. Caligiuri, J. Glorioso, B. Kaur, 2020, Clinical Cancer Research.

Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models

Yue Fang, Y. Otani, H. Dansako, 2023, Cancer science.

Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth

H. Namba, M. Ikeno, S. Amano, 2022, Cancer Gene Therapy.